Navigation Links
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Date:11/18/2011

e study.
(a) After treatment initiation with 3 monthly doses
(b) EYLEA group minus the ranibizumab group

IMPORTANT SAFETY INFORMATION EYLEA™ (aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.

Intravitreal injections, including those with EYLEA, have been associated with endophthalmitis and retinal detachments.  Proper aseptic injection technique must always be used when administering EYLEA.  Patients should be instructed to report any symptoms suggestive of endophthalmitis or retinal detachment without delay and should be managed appropriately.

Acute increases in intraocular pressure have been seen within 60 minutes of intravitreal injection, including with EYLEA.  Sustained increases in intraocular pressure have also been reported after repeated intravitreal dosing with VEGF inhibitors.  Intraocular pressure and the perfusion of the optic nerve head should be monitored and managed appropriately.

There is a potential risk of arterial thromboembolic events (ATEs) following use of intravitreal VEGF inhibitors, including EYLEA, defined as nonfatal stroke, nonfatal myocardial infarction, or vascular death (including deaths of unknown cause).  The incidence of ATEs with EYLEA in clinical trials was low (1.8%).

Serious adverse reactions related to the injection procedure have occurred in less than 0.1% of intravitreal injections with EYLEA including endophthalmitis, traumatic cataract, and increased intraocular pressure.

The most common adverse reactions (greater than or equal to 5%) reported in patients receiving EYLEA were conjunctival hemorrhage, eye pain, cataract, vitreous detachment, vitreous floaters, and increased intraocular pressure.

Please see the full Prescribing Information for EYLEA, available online at

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
2. Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
3. Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
4. Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting
5. Regeneron Reports Second Quarter 2011 Financial and Operating Results
6. Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
7. Trading in Regeneron Common Stock Halted
8. Regeneron Reports First Quarter 2011 Financial and Operating Results
9. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
10. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
11. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... MARLBOROUGH, Mass. , April 1, 2015  Boston Scientific ... on Tuesday, April 28, 2015 at 8 a.m. ET to ... 2015. The company will issue a news release announcing first ... The call will be hosted by Mike Mahoney , ... executive vice president and chief financial officer. A ...
(Date:4/1/2015)... 1, 2015  For many businesses and industries just ... the case, having the right management software can be ... better than software solutions company TraxStar Technologies , ... the company announced the release of the newest version ... "QATrax ...
(Date:4/1/2015)... 1, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... new medical paper has been published describing the ... patients with severe dry eye.  The results met ... physicians stated that statistically significant differences in both ... seen at various time points throughout the study.  ...
Breaking Medicine Technology:Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results 2TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3
... China, April 6, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International ... manufacturer and marketer of medical devices worldwide, announced today ... Equipment Fair ("CMEF") in Shenzhen, China from April 16 ... more than 70 devices from its three core product ...
... BEACH, Fla., April 6, 2011 River Valley ... Messenger have partnered together to add ONC Certified(1) ... major curriculum bullets include: Electronic ... Patient Demographics, Clinical Decision Support, Patient ...
Cached Medicine Technology:Mindray Medical to Exhibit New Products at 65th China International Medical Equipment Fair 2River Valley Community College and Medical Messenger Team Up to Prepare the Future Nurses of New England 2
(Date:4/1/2015)... San Francisco, CA (PRWEB) April 01, 2015 ... aging and senior care, today announces the launch of ... community for innovative senior care stakeholders and technology companies. ... National Investment Center (NIC) Capital and Business Strategies Forum ... 72 'launch' members, the new Alliance program is now ...
(Date:4/1/2015)... 01, 2015 When annoying or concerning ... days or weeks for an appointment with a dermatologist ... next day appointments haven’t been possible within dermatology. However, ... offices have noticed demand for this level of service ... how important relief or answers to dermatological issues are ...
(Date:4/1/2015)... April 01, 2015 SkillSurvey, the leading ... the talent lifecycle, and the premiere provider of on-line ... will feature a webinar on “Using Big Data to ... chief human resources officer of MorseLife, a nationally recognized ... seniors and their families in Palm Beach County. , ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Franklin University, ... proud to announce the establishment of the Greta J. ... is made possible through the generous gift of $100,000 ... gift on behalf of Medical Mutual to University representatives, ... Vice President of Advancement & Strategic Relations. , ...
(Date:4/1/2015)... April 01, 2015 Doctors in Italy ... tremelimumab is more effective against mesothelioma at higher doses. ... on its website. Click here to read it ... at the University Hospital of Siena with unresectable ... standard chemotherapy. When these patients received monthly doses of ...
Breaking Medicine News(10 mins):Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 3Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 2Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 3Health News:New Research Finds Immunotherapy Drug May Fight Mesothelioma Better at Higher Doses, According to Surviving Mesothelioma 2
... The Center for Professional Innovation & Education (CfPIE) announced today ... existing list of highly-successful biotech and pharmaceutical training courses. ... developed to provide life sciences personnel with the kind of ... , ...
... , ... Denver, CO (PRWEB) July 8, 2008 --Innovative Routines ... FL, has just recorded its 30th year in the software industry ... in particular. IRI's flagship CoSort product is used worldwide in legacy ...
... to recruit large percentage of African American ... ... double,a person,s weight loss according to a study from Kaiser Permanente,s Center,for ... loss maintenance trials ever conducted, will be published in,the August issue of ...
... 7 Accuray,Incorporated (Nasdaq: ARAY ), a global ... will report results for its fourth quarter and,fiscal year ... 2008 after,the market closes., A conference call to ... p.m. EDT) and will be hosted by Euan S. ...
... Calif., July 7 Nationwide,Health Properties, Inc. (NYSE: ... second quarter earnings on Wednesday, August 6, 2008 after ... The Company will host a,conference call on Thursday, August ... time) in order to present the Company,s financial,performance and ...
... molecular "smart bombs" to target metastasis with anti-cancer drugs ... toxic chemotherapy, with less collateral damage to surrounding tissue, ... University of California, San Diego. By designing a ... led by Moores UCSD Cancer Center Director of Translational ...
Cached Medicine News:Health News:The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track 2Health News:The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track 3Health News:IRI, The CoSort Company, Marks 30 Years 2Health News:IRI, The CoSort Company, Marks 30 Years 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 2Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 4Health News:Accuray Incorporated to Report Fourth Quarter and Fiscal Year 2008 Financial Results 2Health News:NHP Announces Second Quarter Earnings Release Date and Conference Call/Webcast 2Health News:NHP Announces Second Quarter Earnings Release Date and Conference Call/Webcast 3Health News:'Smart bomb' nanoparticle strategy impacts metastasis 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: